The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family
Open accessAbstract
Immune responses need to be controlled for optimal protective immunity and tolerance. Coinhibitory pathways in the B7-CD28 family provide critical inhibitory signals that regulate immune homeostasis and defense, and protect tissue integrity. These coinhibitory signals limit the strength and duration of immune responses, thereby curbing immune-mediated tissue damage, regulating resolution of inflammation, and maintaining tolerance to prevent autoimmunity. Tumors and microbes that cause chronic infections can exploit these coinhibitory pathways to establish an immunosuppressive microenvironment, hindering their eradication. Advances in understanding T cell coinhibitory pathways have stimulated a new era of immunotherapy with effective drugs to treat cancer, autoimmune and infectious diseases and transplant rejection. In this review we discuss the current knowledge of the mechanisms underlying the coinhibitory functions of pathways in the B7-CD28 family, the diverse functional consequences of these inhibitory signals on immune responses, and the overlapping and unique functions of these key immunoregulatory pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Robert, C., Thomas, L., Bondarenko, I., O'Day, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J.-F., Testori, A., Grob, J.-J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104621 · Cited by 4,496
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Ansell, S. M., Lesokhin, A. M., Borrello, I., Halwani, A., Scott, E. C., Gutierrez, M., Schuster, S. J., Millenson, M. M., Cattry, D., Freeman, G. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411087 · Cited by 3,560
Self-citationMetabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331
Ishida, Y., Agata, Y., Shibahara, K., & Honjo, T. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05481.x · Cited by 3,256
CTLA-4 Control over Foxp3 + Regulatory T Cell Function
Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., & Sakaguchi, S. (2008) · Science · doi:10.1126/science.1160062 · Cited by 2,956
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
Self-citationLymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766
Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., & Sakaguchi, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.303 · Cited by 2,233
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222
Self-citationPosttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chang, C.-H., Curtis, J. D., Maggi, L. B., Faubert, B., Villarino, A. V., O’Sullivan, D., Huang, S. C.-C., van der Windt, G. J. W., Blagih, J., Qiu, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.016 · Cited by 2,204
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
Ueda, H., Howson, J. M. M., Esposito, L., Heward, J., Snook, Chamberlain, G., Rainbow, D. B., Hunter, K. M. D., Smith, A. N., Di Genova, G., et al. (2003) · Nature · doi:10.1038/nature01621 · Cited by 2,175
Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation
Anderson, A. C., Joller, N., & Kuchroo, V. K. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.001 · Cited by 2,096
Michalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., MacIver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., & Rathmell, J. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003613 · Cited by 2,091
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K., & Sharpe, A. H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090847 · Cited by 2,079
Self-citationCTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
Parry, R. V., Chemnitz, J. M., Frauwirth, K. A., Lanfranco, A. R., Braunstein, I., Kobayashi, S. V., Linsley, P. S., Thompson, C. B., & Riley, J. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9543-9553.2005 · Cited by 1,931
Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4
Qureshi, O. S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E. M., Baker, J., Jeffery, L. E., Kaur, S., Briggs, Z., et al. (2011) · Science · doi:10.1126/science.1202947 · Cited by 1,860
Butte, M. J., Keir, M. E., Phamduy, T. B., Sharpe, A. H., & Freeman, G. J. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.016 · Cited by 1,732
Self-citationBretscher, P., & Cohn, M. (1970) · Science · doi:10.1126/science.169.3950.1042 · Cited by 1,692
CTLA-4 is a second receptor for the B cell activation antigen B7.
Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.561 · Cited by 1,685 · cited 1×
“Regulation of CTLA-4 Expression CTLA-4 is induced after activation on CD4+Foxp3 and CD8+Foxp3 conventional T cells (Freeman et al., 1992; Linsley et al., 1992; Walunas et al., 1996) but is constitutively expressed by CD4+Foxp3+ Treg cells (Harper et al., 1991; Lindsten et al., 1993; Takahashi et…”
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,623
Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes
Agata, Y., Kawasaki, A., Nishimura, H., Ishida, Y., Tsubat, T., Yagita, H., & Honjo, T. (1996) · International Immunology · doi:10.1093/intimm/8.5.765 · Cited by 1,589
Hamanishi, J., Mandai, M., Iwasaki, M., Okazaki, T., Tanaka, Y., Yamaguchi, K., Higuchi, T., Yagi, H., Takakura, K., Minato, N., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611533104 · Cited by 1,378
Modulation of tryptophan catabolism by regulatory T cells
Fallarino, F., Grohmann, U., Hwang, K. W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M. L., Fioretti, M. C., Alegre, M.-L., & Puccetti, P. (2003) · Nature Immunology · doi:10.1038/ni1003 · Cited by 1,374
A new member of the immunoglobulin superfamily—CTLA-4
Brunet, J.-F., Denizot, F., Luciani, M.-F., Roux-Dosseto, M., Suzan, M., Mattei, M.-G., & Golstein, P. (1987) · Nature · doi:10.1038/328267a0 · Cited by 1,306
Chemnitz, J. M., Parry, R. V., Nichols, K. E., June, C. H., & Riley, J. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.945 · Cited by 1,246
Patsoukis, N., Bardhan, K., Chatterjee, P., Sari, D., Liu, B., Bell, L. N., Karoly, E. D., Freeman, G. J., Petkova, V., Seth, P., et al. (2015) · Nature Communications · doi:10.1038/ncomms7692 · Cited by 1,202
Self-citationFOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT
Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A. D., Stroud, J. C., Bates, D. L., Guo, L., Han, A., Ziegler, S. F., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.042 · Cited by 1,189
Yokosuka, T., Takamatsu, M., Kobayashi-Imanishi, W., Hashimoto-Tane, A., Azuma, M., & Saito, T. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112741 · Cited by 1,161
CTLA-4–Ig regulates tryptophan catabolism in vivo
Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P., Belladonna, M. L., Bianchi, R., Fioretti, M. C., et al. (2002) · Nature Immunology · doi:10.1038/ni846 · Cited by 1,161
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
Chapoval, A. I., Ni, J., Lau, J. S., Wilcox, R. A., Flies, D. B., Liu, D., Dong, H., Sica, G. L., Zhu, G., Tamada, K., et al. (2001) · Nature Immunology · doi:10.1038/85339 · Cited by 1,015
Chen, L., Gibbons, D. L., Goswami, S., Cortez, M. A., Ahn, Y.-H., Byers, L. A., Zhang, X., Yi, X., Dwyer, D., Lin, W., et al. (2014) · Nature Communications · doi:10.1038/ncomms6241 · Cited by 966
Expression of Programmed Death 1 Ligands by Murine T Cells and APC
Yamazaki, T., Akiba, H., Iwai, H., Matsuda, H., Aoki, M., Tanno, Y., Shin, T., Tsuchiya, H., Pardoll, D. M., Okumura, K., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5538 · Cited by 951
CD28 Costimulation: From Mechanism to Therapy
Esensten, J. H., Helou, Y. A., Chopra, G., Weiss, A., & Bluestone, J. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.020 · Cited by 937 · cited 1×
“The first costimulatory receptor CD28 and the first coinhibitory receptor CTLA-4 and their shared ligands CD80 (B7-1) and CD86 (B7-2) constitute the best-characterized pathway, which serves as a paradigm for other costimulatory (see also Esensten et al., 2016, this issue) and coinhibitory pathways.”
PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection
Petrovas, C., Casazza, J. P., Brenchley, J. M., Price, D. A., Gostick, E., Adams, W. C., Precopio, M. L., Schacker, T., Roederer, M., Douek, D. C., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061496 · Cited by 889
Nomi, T., Sho, M., Akahori, T., Hamada, K., Kubo, A., Kanehiro, H., Nakamura, S., Enomoto, K., Yagita, H., Azuma, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2746 · Cited by 889
Selby, M. J., Engelhardt, J. J., Quigley, M., Henning, K. A., Chen, T., Srinivasan, M., & Korman, A. J. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0013 · Cited by 857
Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4
Kuehn, H. S., Ouyang, W., Lo, B., Deenick, E. K., Niemela, J. E., Avery, D. T., Schickel, J.-N., Tran, D. Q., Stoddard, J., Zhang, Y., et al. (2014) · Science · doi:10.1126/science.1255904 · Cited by 848
Okazaki, T., Maeda, A., Nishimura, H., Kurosaki, T., & Honjo, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231486598 · Cited by 848
Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells
Zheng, Y., Josefowicz, S. Z., Kas, A., Chu, T.-T., Gavin, M. A., & Rudensky, A. Y. (2007) · Nature · doi:10.1038/nature05563 · Cited by 835
Nistico, L. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.7.1075 · Cited by 809
CTLA-4 ligation blocks CD28-dependent T cell activation.
Walunas, T. L., Bakker, C. Y., & Bluestone, J. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2541 · Cited by 801
Ohigashi, Y., Sho, M., Yamada, Y., Tsurui, Y., Hamada, K., Ikeda, N., Mizuno, T., Yoriki, R., Kashizuka, H., Yane, K., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1469 · Cited by 796
Sheppard, K.-A., Fitz, L. J., Lee, J. M., Benander, C., George, J. A., Wooters, J., Qiu, Y., Jussif, J. M., Carter, L. L., Wood, C. R., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.083 · Cited by 791
Prokunina, L., Castillejo-López, C., Öberg, F., Gunnarsson, I., Berg, L., Magnusson, V., Brookes, A. J., Tentler, D., Kristjansdóttir, H., Gröndal, G., et al. (2002) · Nature Genetics · doi:10.1038/ng1020 · Cited by 769
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR–induced stop signal
Fife, B. T., Pauken, K. E., Eagar, T. N., Obu, T., Wu, J., Tang, Q., Azuma, M., Krummel, M. F., & Bluestone, J. A. (2009) · Nature Immunology · doi:10.1038/ni.1790 · Cited by 759
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma
Kryczek, I., Zou, L., Rodriguez, P., Zhu, G., Wei, S., Mottram, P., Brumlik, M., Cheng, P., Curiel, T., Myers, L., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050930 · Cited by 748
B7-H4, a Molecule of the B7 Family, Negatively Regulates T Cell Immunity
Sica, G. L., Choi, I.-H., Zhu, G., Tamada, K., Wang, S.-D., Tamura, H., Chapoval, A. I., Flies, D. B., Bajorath, J., & Chen, L. (2003) · Immunity · doi:10.1016/s1074-7613(03)00152-3 · Cited by 713
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
Wang, L., Rubinstein, R., Lines, J. L., Wasiuk, A., Ahonen, C., Guo, Y., Lu, L.-F., Gondek, D., Wang, Y., Fava, R. A., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100619 · Cited by 710
The Interaction Properties of Costimulatory Molecules Revisited
Collins, A. V., Brodie, D. W., Gilbert, R. J. C., Iaboni, A., Manso-Sancho, R., Walse, B., Stuart, D. I., van der Merwe, P. A., & Davis, S. J. (2002) · Immunity · doi:10.1016/s1074-7613(02)00362-x · Cited by 684
Lo, B., Zhang, K., Lu, W., Zheng, L., Zhang, Q., Kanellopoulou, C., Zhang, Y., Liu, Z., Fritz, J. M., Marsh, R., et al. (2015) · Science · doi:10.1126/science.aaa1663 · Cited by 675
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells
Loke, P., & Allison, J. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931259100 · Cited by 634
Intracellular Trafficking of CTLA-4 and Focal Localization Towards Sites of TCR Engagement
Linsley, P. S., Bradshaw, J., Greene, J., Peach, R., Bennett, K. L., & Mittler, R. S. (1996) · Immunity · doi:10.1016/s1074-7613(00)80480-x · Cited by 609
Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
Linsley, P. S., Greene, J. L., Tan, P., Bradshaw, J., Ledbetter, J. A., Anasetti, C., & Damle, N. K. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1595 · Cited by 581
The B7 family member B7-H3 preferentially down-regulates T helper type 1–mediated immune responses
Suh, W.-K., Gajewska, B. U., Okada, H., Gronski, M. A., Bertram, E. M., Dawicki, W., Duncan, G. S., Bukczynski, J., Plyte, S., Elia, A., et al. (2003) · Nature Immunology · doi:10.1038/ni967 · Cited by 576
A NEW ANALYSIS OF ALLOGENEIC INTERACTIONS
Lafferty, K., & Cunningham, A. (1975) · Australian Journal of Experimental Biology and Medical Science · doi:10.1038/icb.1975.3 · Cited by 556
Patsoukis, N., Brown, J., Petkova, V., Liu, F., Li, L., & Boussiotis, V. A. (2012) · Science Signaling · doi:10.1126/scisignal.2002796 · Cited by 529
VISTA is an immune checkpoint molecule for human T cells
Lines, J. L., Pantazi, E., Mak, J., Sempere, L. F., Wang, L., O'Connell, S., Ceeraz, S., Suriawinata, A. A., Yan, S., Ernstoff, M. S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1504 · Cited by 510
Sarcoidosis is associated with a truncating splice site mutation in BTNL2
Valentonyte, R., Hampe, J., Huse, K., Rosenstiel, P., Albrecht, M., Stenzel, A., Nagy, M., Gaede, K. I., Franke, A., Haesler, R., et al. (2005) · Nature Genetics · doi:10.1038/ng1519 · Cited by 491
Kao, C., Oestreich, K. J., Paley, M. A., Crawford, A., Angelosanto, J. M., Ali, M.-A. A., Intlekofer, A. M., Boss, J. M., Reiner, S. L., Weinmann, A. S., et al. (2011) · Nature Immunology · doi:10.1038/ni.2046 · Cited by 484
Targeting T Cell Co-receptors for Cancer Therapy
Callahan, M. K., Postow, M. A., & Wolchok, J. D. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.023 · Cited by 469
The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses
Ward-Kavanagh, L. K., Lin, W. W., Šedý, J. R., & Ware, C. F. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.019 · Cited by 463
Sage, P. T., Paterson, A. M., Lovitch, S. B., & Sharpe, A. H. (2014) · Immunity · doi:10.1016/j.immuni.2014.12.005 · Cited by 437
Self-citationHarper, K., Balzano, C., Rouvier, E., Mattéi, M. G., Luciani, M. F., & Golstein, P. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.3.1037 · Cited by 432
Youngblood, B., Oestreich, K. J., Ha, S.-J., Duraiswamy, J., Akondy, R. S., West, E. E., Wei, Z., Lu, P., Austin, J. W., Riley, J. L., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.06.015 · Cited by 419
NFATc1 Regulates PD-1 Expression upon T Cell Activation
Oestreich, K. J., Yoon, H., Ahmed, R., & Boss, J. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4832 · Cited by 416
CTLA-4 in autoimmune diseases – a general susceptibility gene to autoimmunity?
Kristiansen, O., Larsen, Z., & Pociot, F. (2000) · Genes & Immunity · doi:10.1038/sj.gene.6363655 · Cited by 414
Structural and Functional Analysis of the Costimulatory Receptor Programmed Death-1
Zhang, X., Schwartz, J.-C. D., Guo, X., Bhatia, S., Cao, E., Chen, L., Zhang, Z.-Y., Edidin, M. A., Nathenson, S. G., & Almo, S. C. (2004) · Immunity · doi:10.1016/s1074-7613(04)00051-2 · Cited by 410
CTLA4 Alanine-17 Confers Genetic Susceptibility to Graves’ Disease and to Type 1 Diabetes Mellitus1
Donner, H., Rau, H., Walfish, P. G., Braun, J., Siegmund, T., Finke, R., Herwig, J., Usadel, K. H., & Badenhoop, K. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3699 · Cited by 396
Wing, J. B., Ise, W., Kurosaki, T., & Sakaguchi, S. (2014) · Immunity · doi:10.1016/j.immuni.2014.12.006 · Cited by 388
The B7 family of immune-regulatory ligands.
Collins, M. A., Ling, V., & Carreno, B. M. (2005) · Genome biology · doi:10.1186/gb-2005-6-6-223 · Cited by 388
Staron, M. M., Gray, S. M., Marshall, H. D., Parish, I. A., Chen, J. H., Perry, C. J., Cui, G., Li, M. O., & Kaech, S. M. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.013 · Cited by 385
Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses
Liu, J., Yuan, Y., Chen, W., Putra, J., Suriawinata, A. A., Schenk, A. D., Miller, H. E., Guleria, I., Barth, R. J., Huang, Y. H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420370112 · Cited by 374
Murine B7-H3 is a negative regulator of T cells
Prasad, D. V. R., Nguyen, T., Li, Z., Yang, Y., Duong, J., Wang, Y., & Dong, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2500 · Cited by 368 · cited 2×
“B7-H3 is constitutively expressed on murine APCs (Collins et al., 2005), but inducibly expressed on human T cells, NK cells, DCs, macrophages, and monocytes (Chapoval et al., 2001; Prasad et al., 2004; Steinberger et al., 2004; Suh et al., 2003).”
Frigola, X., Inman, B. A., Lohse, C. M., Krco, C. J., Cheville, J. C., Thompson, R. H., Leibovich, B., Blute, M. L., Dong, H., & Kwon, E. D. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0250 · Cited by 345
Terawaki, S., Chikuma, S., Shibayama, S., Hayashi, T., Yoshida, T., Okazaki, T., & Honjo, T. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003208 · Cited by 342
Regulation of surface and intracellular expression of CTLA4 on mouse T cells
Alegre, M. L., Noel, P. J., Eisfelder, B. J., Chuang, E., Clark, M. R., Reiner, S. L., & Thompson, C. B. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.11.4762 · Cited by 338 · cited 1×
“…T cells; the majority of CTLA-4 molecules are localized in the intracellular compartments of perinuclear Golgi vesicles, endosomes, and lysosomes (Alegre et al., 1996; Iida et al., 2000; Linsley et al., 1996; Schneider et al., 1999), and cycle continuously to the cell surface, followed by rapid…”
TIM3+FOXP3+regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer
Sakuishi, K., Ngiow, S. F., Sullivan, J. M., Teng, M. W. L., Kuchroo, V. K., Smyth, M. J., & Anderson, A. C. (2013) · OncoImmunology · doi:10.4161/onci.23849 · Cited by 328
Xiao, Y., Yu, S., Zhu, B., Bedoret, D., Bu, X., Francisco, L. M., Hua, P., Duke-Cohan, J. S., Umetsu, D. T., Sharpe, A. H., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20130790 · Cited by 321
Self-citationSonkoly, E., Janson, P., Majuri, M.-L., Savinko, T., Fyhrquist, N., Eidsmo, L., Xu, N., Meisgen, F., Wei, T., Bradley, M., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.05.045 · Cited by 317
Characterization of CTLA-4 structure and expression on human T cells.
Lindsten, T., Lee, K. P., Harris, E. S., Petryniak, B., Craighead, N., Reynolds, P. J., Lombard, D. B., Freeman, G. J., Nadler, L. M., Gray, G. S., et al. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.7.3489 · Cited by 316
Self-citationB7 family checkpoint regulators in immune regulation and disease
Ceeraz, S., Nowak, E. C., & Noelle, R. J. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.07.003 · Cited by 307
Krambeck, A. E., Thompson, R. H., Dong, H., Lohse, C. M., Park, E. S., Kuntz, S. M., Leibovich, B. C., Blute, M. L., Cheville, J. C., & Kwon, E. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600937103 · Cited by 305
Strength of PD-1 signaling differentially affects T-cell effector functions
Wei, F., Zhong, S., Ma, Z., Kong, H., Medvec, A., Ahmed, R., Freeman, G. J., Krogsgaard, M., & Riley, J. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305394110 · Cited by 304
Self-citationThe CD28 and CTLA-4 Receptors Associate with the Serine/Threonine Phosphatase PP2A
Chuang, E., Fisher, T. S., Morgan, R. W., Robbins, M. D., Duerr, J. M., Vander Heiden, M. G., Gardner, J. P., Hambor, J. E., Neveu, M. J., & Thompson, C. B. (2000) · Immunity · doi:10.1016/s1074-7613(00)00031-5 · Cited by 303
Dariavach, P., Mattéi, M., Golstein, P., & Lefranc, M. (1988) · European Journal of Immunology · doi:10.1002/eji.1830181206 · Cited by 301
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity
Zhang, Q., & Vignali, D. A. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.017 · Cited by 296
Characterization of Mouse and Human B7-H3 Genes
Sun, M., Richards, S., Prasad, D. V. R., Mai, X. M., Rudensky, A., & Dong, C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6294 · Cited by 295
Anjos, S., Nguyen, A., Ounissi-Benkalha, H., Tessier, M.-C., & Polychronakos, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206894200 · Cited by 293
B7‐H3 is a potent inhibitor of human T‐cell activation: No evidence for B7‐H3 and TREML2 interaction
Leitner, J., Klauser, C., Pickl, W. F., Stöckl, J., Majdic, O., Bardet, A. F., Kreil, D. P., Dong, C., Yamazaki, T., Zlabinger, G., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200839028 · Cited by 290
CTLA4 Alanine-17 Confers Genetic Susceptibility to Graves' Disease and to Type 1 Diabetes Mellitus
Donner, H. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.1.143 · Cited by 284
Coinhibitory receptor PD-1H preferentially suppresses CD4+ T cell–mediated immunity
Flies, D. B., Han, X., Higuchi, T., Zheng, L., Sun, J., Ye, J. J., & Chen, L. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74589 · Cited by 282
Kryczek, I., Wei, S., Zou, L., Zhu, G., Mottram, P., Xu, H., Chen, L., & Zou, W. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.40 · Cited by 277
Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2
Ungewickell, A., Bhaduri, A., Rios, E., Reuter, J., Lee, C. S., Mah, A., Zehnder, A., Ohgami, R., Kulkarni, S., Armstrong, R., et al. (2015) · Nature Genetics · doi:10.1038/ng.3370 · Cited by 277
Molecular Characterization of Human 4Ig-B7-H3, a Member of the B7 Family with Four Ig-Like Domains
Steinberger, P., Majdic, O., Derdak, S. V., Pfistershammer, K., Kirchberger, S., Klauser, C., Zlabinger, G., Pickl, W. F., Stöckl, J., & Knapp, W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2352 · Cited by 276
Magistrelli, G., Jeannin, P., Herbault, N., Benoit de Coignac, A., Gauchat, J.-F., Bonnefoy, J.-Y., & Delneste, Y. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199911)29:11<3596::aid-immu3596>3.0.co;2-y · Cited by 276
Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells
Eppihimer, M., Gunn, J., Freeman, G., Greenfield, E., Chernova, T., Erickson, J., & Leonard, J. (2002) · Microcirculation · doi:10.1080/713774061 · Cited by 272
Self-citationXu, H., Cheung, I. Y., Guo, H.-F., & Cheung, N.-K. V. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4517 · Cited by 264
Nishimura, H., Agata, Y., Kawasaki, A., Sato, M., Imamura, S., Minato, N., Yagita, H., Nakano, T., & Honjo, T. (1996) · International Immunology · doi:10.1093/intimm/8.5.773 · Cited by 261
A Native Soluble Form of CTLA-4
Oaks, M. K., Hallett, K. M., Penwell, R. T., Stauber, E. C., Warren, S. J., & Tector, A. J. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1649 · Cited by 256
Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease
Attanasio, J., & Wherry, E. J. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.022 · Cited by 256
Structure and Chromosomal Localization of the Human PD-1 Gene (PDCD1)
Shinohara, T., Taniwaki, M., Ishida, Y., Kawaichi, M., & Honjo, T. (1994) · Genomics · doi:10.1006/geno.1994.1562 · Cited by 253
A PD‐1 polymorphism is associated with disease progression in multiple sclerosis
Kroner, A., Mehling, M., Hemmer, B., Rieckmann, P., Toyka, K. V., Mäurer, M., & Wiendl, H. (2005) · Annals of Neurology · doi:10.1002/ana.20514 · Cited by 249
Flies, D. B., Wang, S., Xu, H., & Chen, L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100660 · Cited by 249
Choi, I.-H., Zhu, G., Sica, G. L., Strome, S. E., Cheville, J. C., Lau, J. S., Zhu, Y., Flies, D. B., Tamada, K., & Chen, L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4650 · Cited by 246
T‐cell tolerance or function is determined by combinatorial costimulatory signals
Nurieva, R., Thomas, S., Nguyen, T., Martin‐Orozco, N., Wang, Y., Kaja, M., Yu, X., & Dong, C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601146 · Cited by 245
Polanczyk, M. J., Hopke, C., Vandenbark, A. A., & Offner, H. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20881 · Cited by 244
Cutting Edge: Lymphoproliferative Disease in the Absence of CTLA-4 Is Not T Cell Autonomous
Bachmann, M. F., Köhler, G., Ecabert, B., Mak, T. W., & Kopf, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1128 · Cited by 235
Wan, B., Nie, H., Liu, A., Feng, G., He, D., Xu, R., Zhang, Q., Dong, C., & Zhang, J. Z. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8844 · Cited by 233
Hashiguchi, M., Kobori, H., Ritprajak, P., Kamimura, Y., Kozono, H., & Azuma, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802423105 · Cited by 227
Alternative splice variants of the human PD-1 gene
Nielsen, C., Ohm-Laursen, L., Barington, T., Husby, S., & Lillevang, S. T. (2005) · Cellular Immunology · doi:10.1016/j.cellimm.2005.07.007 · Cited by 226
Han, Y., Chen, Z., Yang, Y., Jiang, Z., Gu, Y., Liu, Y., Lin, C., Pan, Z., Yu, Y., Jiang, M., et al. (2014) · Hepatology · doi:10.1002/hep.26694 · Cited by 226
Vijayakrishnan, L., Slavik, J. M., Illés, Z., Greenwald, R. J., Rainbow, D., Greve, B., Peterson, L. B., Hafler, D. A., Freeman, G. J., Sharpe, A. H., et al. (2004) · Immunity · doi:10.1016/s1074-7613(04)00110-4 · Cited by 218
Self-citationGong, A.-Y., Zhou, R., Hu, G., Li, X., Splinter, P. L., O'Hara, S. P., LaRusso, N. F., Soukup, G. A., Dong, H., & Chen, X.-M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1325 · Cited by 217
Salceda, S., Tang, T., Kmet, M., Munteanu, A., Ghosh, M., Macina, R., Liu, W., Pilkington, G., & Papkoff, J. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.01.018 · Cited by 217
Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity
Paterson, A. M., Lovitch, S. B., Sage, P. T., Juneja, V. R., Lee, Y., Trombley, J. D., Arancibia-Cárcamo, C. V., Sobel, R. A., Rudensky, A. Y., Kuchroo, V. K., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141030 · Cited by 212
Self-citationHHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function
Zhao, R., Chinai, J. M., Buhl, S., Scandiuzzi, L., Ray, A., Jeon, H., Ohaegbulam, K. C., Ghosh, K., Zhao, A., Scharff, M. D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303524110 · Cited by 208
A CTLA-4 gene polymorphism at position −318 in the promoter region affects the expression of protein
Wang, X. B., Zhao, X., Giscombe, R., & Lefvert, A. K. (2002) · Genes & Immunity · doi:10.1038/sj.gene.6363869 · Cited by 206
BTNL2, a Butyrophilin-Like Molecule That Functions to Inhibit T Cell Activation
Nguyen, T., Liu, X. K., Zhang, Y., & Dong, C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7354 · Cited by 195
Wang, L., Le Mercier, I., Putra, J., Chen, W., Liu, J., Schenk, A. D., Nowak, E. C., Suriawinata, A. A., Li, J., & Noelle, R. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407447111 · Cited by 195
Zhang, G., Hou, J., Shi, J., Yu, G., Lu, B., & Zhang, X. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02723.x · Cited by 192
Patsoukis, N., Li, L., Sari, D., Petkova, V., & Boussiotis, V. A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00319-13 · Cited by 187
B7-H5 costimulates human T cells via CD28H
Zhu, Y., Yao, S., Iliopoulou, B. P., Han, X., Augustine, M. M., Xu, H., Phennicie, R. T., Flies, S. J., Broadwater, M., Ruff, W., et al. (2013) · Nature Communications · doi:10.1038/ncomms3043 · Cited by 186
Luo, L., Chapoval, A. I., Flies, D. B., Zhu, G., Hirano, F., Wang, S., Lau, J. S., Dong, H., Tamada, K., Flies, A. S., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5445 · Cited by 181
CTLA‐4: a key regulatory point in the control of autoimmune disease
Scalapino, K. J., & Daikh, D. I. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00639.x · Cited by 176
Stojanovic, A., Fiegler, N., Brunner-Weinzierl, M., & Cerwenka, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302091 · Cited by 175
Iida, T., Ohno, H., Nakaseko, C., Sakuma, M., Takeda-Ezaki, M., Arase, H., Kominami, E., Fujisawa, T., & Saito, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.5062 · Cited by 173
Constitutive Clathrin-mediated Endocytosis of CTLA-4 Persists during T Cell Activation
Qureshi, O. S., Kaur, S., Hou, T. Z., Jeffery, L. E., Poulter, N. S., Briggs, Z., Kenefeck, R., Willox, A. K., Royle, S. J., Rappoport, J. Z., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.304329 · Cited by 172
Ise, W., Kohyama, M., Nutsch, K. M., Lee, H. M., Suri, A., Unanue, E. R., Murphy, T. L., & Murphy, K. M. (2010) · Nature Immunology · doi:10.1038/ni.1835 · Cited by 171
Schneider, H., Martín, M., Agarraberes, F. A., Yin, L., Rapoport, I., Kirchhausen, T. L., & Rudd, C. E. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.1868 · Cited by 171
Liu, Y., Carlsson, R., Comabella, M., Wang, J., Kosicki, M., Carrión, B., Hasan, M., Wu, X., Montalbán, X., Dziegiel, M. H., et al. (2014) · Nature Medicine · doi:10.1038/nm.3485 · Cited by 167
Austin, J. W., Lu, P., Majumder, P., Ahmed, R., & Boss, J. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302750 · Cited by 167
NF-κB Regulates PD-1 Expression in Macrophages
Bally, A. P. R., Lu, P., Tang, Y., Austin, J. W., Scharer, C. D., Ahmed, R., & Boss, J. M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402550 · Cited by 166
Lu, P., Youngblood, B., Austin, J. W., Mohammed, A. U. R., Butler, R., Ahmed, R., & Boss, J. M. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20130208 · Cited by 165
Structure of Murine CTLA-4 and Its Role in Modulating T Cell Responsiveness
Ostrov, D. A., Shi, W., Schwartz, J.-C. D., Almo, S. C., & Nathenson, S. G. (2000) · Science · doi:10.1126/science.290.5492.816 · Cited by 164
Mueller, S. N., Vanguri, V. K., Ha, S.-J., West, E. E., Keir, M. E., Glickman, J. N., Sharpe, A. H., & Ahmed, R. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40040 · Cited by 160
Self-citationChang, W., Kim, J., Kim, Y., Kim, Y.-S., Lee, J.-M., Azuma, M., Yagita∥, H., & Kang, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.6707 · Cited by 154
Janakiram, M., Chinai, J. M., Fineberg, S., Fiser, A., Montagna, C., Medavarapu, R., Castano, E., Jeon, H., Ohaegbulam, K. C., Zhao, R., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1495 · Cited by 154
Freeman, G. J., Lombard, D. B., Gimmi, C. D., Brod, S. A., Lee, K., Laning, J. C., Hafler, D. A., Dorf, M. E., Gray, G. S., & Reiser, H. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.12.3795 · Cited by 150
Self-citationExpression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells.
Eppihimer, M. J., Gunn, J., Freeman, G. J., Greenfield, E. A., Chernova, T., Erickson, J., & Leonard, J. P. (2002) · PubMed · doi:10.1038/sj/mn/7800123 · Cited by 149
Self-citationSolution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28
Metzler, W. J., Bajorath, J., Fenderson, W., Shaw, S., Constantine, K. L., Naemura, J. R., Leytze, G., Peach, R., Lavoie, T., Mueller, L., et al. (1997) · Nature Structural Biology · doi:10.1038/nsb0797-527 · Cited by 147
Protein kinase C-η controls CTLA-4–mediated regulatory T cell function
Kong, K., Fu, G., Zhang, Y., Yokosuka, T., Casas, J., Canonigo-Balancio, A. J., Bécart, S., Kim, G., Yates, J. R., Kronenberg, M., et al. (2014) · Nature Immunology · doi:10.1038/ni.2866 · Cited by 147
Mager, D. L., Hunter, D. G., Schertzer, M. J., & Freeman, J. (1999) · Genomics · doi:10.1006/geno.1999.5877 · Cited by 142
Arnett, H. A., Escobar, S. M., González‐Suárez, E., Budelsky, A., Steffen, L. A., Boiani, N., Zhang, M., Siu, G., Brewer, A. W., & Viney, J. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1523 · Cited by 139
Notch signaling regulates PD‐1 expression during CD8 + T‐cell activation
Mathieu, M., Cotta‐Grand, N., Daudelin, J., Thébault, P., & Labrecque, N. (2012) · Immunology and Cell Biology · doi:10.1038/icb.2012.53 · Cited by 136
Schneider, H., Martı́n, M., Agarraberes, F. A., Yin, L., Rapoport, I., Kirchhausen, T. L., & Rudd, C. E. (1999) · PubMed · Cited by 134
Activator protein 1 suppresses antitumor T-cell function via the induction of programmed death 1
Xiao, G., Deng, A., Liu, H., Ge, G., & Liu, X. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206370109 · Cited by 133
Pistillo, M. P., Tazzari, P. L., Palmisano, G. L., Pierri, I., Bolognesi, A., Ferlito, F., Capanni, P., Polito, L., Ratta, M., Pileri, S., et al. (2002) · Blood · doi:10.1182/blood-2002-06-1668 · Cited by 133
Mouse B7-H3 induces antitumor immunity
Sun, X., Vale, M., Leung, E. Y., Kanwar, J. R., Gupta, R., & Krissansen, G. W. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302070 · Cited by 132
Wicker, L. S., Chamberlain, G., Hunter, K. M. D., Rainbow, D. B., Howlett, S., Tiffen, P. G., Clark, J., González-Muñoz, A., Cumiskey, A. M., Rosa, R. L., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.164 · Cited by 126
CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions
Laurent, S., Carrega, P., Saverino, D., Piccioli, P., Camoriano, M., Morabito, A., Dozin, B., Fontana, V., Simone, R., Mortara, L., et al. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.07.007 · Cited by 121
B7‐H3 and Its Role in Antitumor Immunity
Loos, M., Hedderich, D. M., Friess, H., & Kleeff, J. H. (2010) · Journal of Immunology Research · doi:10.1155/2010/683875 · Cited by 120
Induction of the CTLA-4 Gene in Human Lymphocytes Is Dependent on NFAT Binding the Proximal Promoter
Gibson, H. M., Hedgcock, C. J., Aufiero, B. M., Wilson, A. J., Hafner, M. S., Tsokos, G. C., & Wong, H. K. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3831 · Cited by 119
Cutting Edge: CTLA-4–B7 Interaction Suppresses Th17 Cell Differentiation
Ying, H., Yang, L., Qiao, G., Li, Z., Zhang, L., Yin, F., Xie, D., & Zhang, J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903369 · Cited by 118
Liu, Y., Yu, Y., Yang, S., Zeng, B., Zhang, Z., Jiao, G., Zhang, Y., Cai, L., & Yang, R. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0591-5 · Cited by 117
Schneider, H., Smith, X., Liu, H., Bismuth, G., & Rudd, C. E. (2008) · European Journal of Immunology · doi:10.1002/eji.200737423 · Cited by 116 · cited 1×
“Several other mechanisms have also been reported, including inhibition of microclusters and activation of E3 ligases (Chattopadhyay and Shevach, 2013; Schneider et al., 2008).”
Binding Stoichiometry of the Cytotoxic T Lymphocyte-associated Molecule-4 (CTLA-4)
Linsley, P. S., Nadler, S. G., Bajorath, J., Peach, R., Leung, H. T. C., Rogers, J., Bradshaw, J., Stebbins, M. R., Leytze, G., Brady, W., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.15417 · Cited by 114
Cutting Edge: CTLA-4 on Effector T Cells Inhibits In Trans
Corse, E., & Allison, J. P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200695 · Cited by 111
Tai, X., Laethem, F. V., Sharpe, A. H., & Singer, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706509104 · Cited by 109
Self-citationZhang, L., Wu, H., Lu, D., Li, G., Sun, C., Song, H., Li, J., Zhai, T., Huang, L., Hou, C., et al. (2013) · Oncogene · doi:10.1038/onc.2012.600 · Cited by 108
Cho, H.-Y., Lee, S.-W., Seo, S., Choi, I., Choi, I., & Lee, S.-W. (2008) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2008.08.003 · Cited by 104
Mead, K. I., Zheng, Y., Manzotti, C. N., Perry, L., Liu, M. K. P., Burke, F., Powner, D., Wakelam, M. J. O., & Sansom, D. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4803 · Cited by 102
B7‐H3 promotes acute and chronic allograft rejection
Wang, L., Fraser, C. C., Kikly, K. K., Wells, A. D., Han, R., Coyle, A. J., Chen, L., & Hancock, W. W. (2005) · European Journal of Immunology · doi:10.1002/eji.200425518 · Cited by 102
Gerold, K. D., Zheng, P., Rainbow, D. B., Zernecke, A., Wicker, L. S., & Kissler, S. (2011) · Diabetes · doi:10.2337/db11-0130 · Cited by 102
CTLA-4 regulates the requirement for cytokine-induced signals in TH2 lineage commitment
Bour-Jordan, H., Grogan, J. L., Tang, Q., Auger, J., Locksley, R. M., & Bluestone, J. A. (2003) · Nature Immunology · doi:10.1038/ni884 · Cited by 100
B7-H3 Augments the Inflammatory Response and Is Associated with Human Sepsis
Zhang, G., Wang, J., Kelly, J., Gu, G., Hou, J., Zhou, Y., Redmond, H. P., Wang, J. H., & Zhang, X. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904020 · Cited by 94
Cutting Edge: Cell-Extrinsic Immune Regulation by CTLA-4 Expressed on Conventional T Cells
Wang, C. J., Kenefeck, R., Wardzinski, L., Attridge, K., Manzotti, C. N., Schmidt, E. M., Qureshi, O., Sansom, D. M., & Walker, L. S. K. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200972 · Cited by 92
Expression of CTLA‐4 by Human Monocytes
Wang, X. ‐., Giscombe, R., Yan, Z., Heiden, T., Xu, D., & Lefvert, A. K. (2002) · Scandinavian Journal of Immunology · doi:10.1046/j.0300-9475.2001.01019.x · Cited by 90
Personalized treatment of Sézary syndrome by targeting a novel CTLA 4: CD 28 fusion
Sekulić, A., Liang, W. S., Tembe, W., Izatt, T., Kruglyak, S., Kiefer, J., Cuyugan, L., Zismann, V., Legendre, C., Pittelkow, M. R., et al. (2014) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.121 · Cited by 90
Chattopadhyay, G., & Shevach, E. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301693 · Cited by 90
Inhibition of IgG1 and IgE Production by Stimulation of the B Cell CTLA-4 Receptor
Pioli, C., Gatta, L., Ubaldi, V., & Doria, G. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5530 · Cited by 89
The CTLA-4 gene is expressed in placental fibroblasts
Kaufman, K. A., Bowen, J. A., Tsai, A. F., Bluestone, J. A., Hunt, J. S., & Ober, C. (1999) · Molecular Human Reproduction · doi:10.1093/molehr/5.1.84 · Cited by 88
Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma
Yoo, H. Y., Kim, N., Kim, W. S., Lee, S., Kim, S., Kang, S. Y., Jang, H.-Y., Lee, J. E., Kim, J., Kim, S. J., et al. (2016) · Haematologica · doi:10.3324/haematol.2015.139253 · Cited by 88
Hamilton, N. H. R., Banyer, J., Hapel, A. J., Mahalingam, S., Ramsay, A. J., Ramshaw, I. A., & Thomson, S. A. (2002) · PubMed · Cited by 87
Zhang, G., Li, N., Zhu, L., Zhu, Q., Li, F., Yang, C., Han, Q., Lv, Y., Zhou, Z.-H., & Liu, Z. (2015) · Oncotarget · doi:10.18632/oncotarget.3662 · Cited by 86
Finn, P. W., He, H., Wang, Y., Wang, Z., Guan, G., Listman, J. A., & Perkins, D. L. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.9.4074 · Cited by 85
Araki, M., Chung, D., Liu, S. M., Rainbow, D. B., Chamberlain, G., Garner, V. E. S., Hunter, K. M. D., Vijayakrishnan, L., Peterson, L. B., Oukka, M., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802610 · Cited by 84
Self-citationHe, X., Xu, L., & Liu, Y. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00086.x · Cited by 81
B7-H4–deficient mice display augmented neutrophil-mediated innate immunity
Zhu, G., Augustine, M. M., Azuma, T., Luo, L., Yao, S., Anand, S., Rietz, A. C., Huang, J., Xu, H., Flies, A. S., et al. (2008) · Blood · doi:10.1182/blood-2008-01-133223 · Cited by 81
Valk, E., Leung, R., Kang, H., Kaneko, K., Rudd, C. E., & Schneider, H. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.024 · Cited by 78
Generation and Characterization of B7-H4/B7S1/B7x-Deficient Mice
Suh, W., Wang, S., Duncan, G. S., Miyazaki, Y., Cates, E. C., Walker, T. D., Gajewska, B., Deenick, E. K., Dawicki, W., Okada, H., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00755-06 · Cited by 78
PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice
Zhou, J., Cheung, A. K. L., Tan, Z., Wang, H., Yu, W., Du, Y., Kang, Y., Lu, X., Liu, L., Yuen, K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64704 · Cited by 73
T Cell Cosignaling Molecules in Transplantation
Ford, M. L. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.012 · Cited by 70
Host B7x Promotes Pulmonary Metastasis of Breast Cancer
Abadi, Y. M., Jeon, H., Ohaegbulam, K. C., Scandiuzzi, L., Ghosh, K., Hofmeyer, K. A., Lee, J. S., Ray, A., Gravekamp, C., & Zang, X. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202439 · Cited by 69
Yao, Y., Wang, X., Jin, K., Zhu, J., Wang, Y., Xiong, S., Mao, Y. Q., & Zhou, L. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9601-x · Cited by 67
B7-H4 Expression Promotes Tumorigenesis in Ovarian Cancer
Cheng, L., Jiang, J., Gao, R., Wei, S., Nan, F., Li, S., & Kong, B. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181ad0fa2 · Cited by 64
Swanson, R., Gavin, M. A., Escobar, S. M., Rottman, J. B., Lipsky, B. P., Dube, S., Li, L., Bigler, J., Wolfson, M. F., Arnett, H. A., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201760 · Cited by 64
Aloia, L., Parisi, S., Fusco, L., Pastore, L., & Russo, T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077156 · Cited by 56
Cell‐extrinsic CTLA 4‐mediated regulation of dendritic cell maturation depends on STAT 3
Kowalczyk, A., D’Souza, C. A., & Zhang, L. (2013) · European Journal of Immunology · doi:10.1002/eji.201343601 · Cited by 54
A New B7:CD28 Family Checkpoint Target for Cancer Immunotherapy: HHLA2
Xiao, Y., & Freeman, G. J. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2658 · Cited by 53
Self-citationGI24 enhances tumor invasiveness by regulating cell surface membrane‐type 1 matrix metalloproteinase
Sakr, M., Takino, T., Domoto, T., Nakano, H., Wong, R. W.-C., Sasaki, M., Nakanuma, Y., & Sato, H. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01675.x · Cited by 46
Sun, J., Fu, F., Gu, W., Yan, R., Zhang, G., Shen, Z., Zhou, Y., Wang, H., Shen, B., & Zhang, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024751 · Cited by 44
Investigation of Soluble and Transmembrane CTLA-4 Isoforms in Serum and Microvesicles
Esposito, L., Hunter, K. M. D., Clark, J., Rainbow, D. B., Stevens, H. E., Denesha, J., Duley, S., Dawson, S., Coleman, G., Nutland, S. L., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303389 · Cited by 41
Post-transcriptional control of candidate risk genes for type 1 diabetes by rare genetic variants
de Jong, V. M., Zaldumbide, A., van der Slik, A. R., Persengiev, S. P., Roep, B. O., & Koeleman, B. P. C. (2012) · Genes and Immunity · doi:10.1038/gene.2012.38 · Cited by 36
Zhong, X., Bai, C., Gao, W., Strom, T. B., & Rothstein, T. L. (2004) · International Immunology · doi:10.1093/intimm/dxh121 · Cited by 34
Chen, X., Zhang, G., Li, Y., Xing, F., Wan, F., Zhang, L., Wang, J., & Zhang, X. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9133-z · Cited by 32
The 3′ UTR of the human CTLA4 mRNA can regulate mRNA stability and translational efficiency
Malquori, L., Carsetti, L., & Ruberti, G. (2007) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2007.10.004 · Cited by 31
Forni, D., Cagliani, R., Pozzoli, U., Colleoni, M., Riva, S., Biasin, M., Filippi, G., GIOIA, L. D., Gnudi, F., Comi, G. P., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.008 · Cited by 30
Pérez-García, A., Osca‐Gelis, G., Bosch-Vizcaya, A., Kelleher, N., Santos, N., Rodríguez-Romanos, R., González, Y., Roncero, J. M., Coll, R., Serrando, M., et al. (2013) · Human Immunology · doi:10.1016/j.humimm.2013.05.012 · Cited by 29
Cited by
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Wei, S. C., Duffy, C. R., & Allison, J. P. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0367 · Cited by 3,088
The diverse functions of the PD1 inhibitory pathway
Sharpe, A. H., & Pauken, K. E. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.108 · Cited by 1,971
Self-citationMechanisms Controlling PD-L1 Expression in Cancer
Cha, J.-H., Chan, L.-C., Li, C.-W., Hsu, J. L., & Hung, M.-C. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.09.030 · Cited by 1,045
Pitt, J. M., Vétizou, M., Daillère, R., Roberti, M. P., Yamazaki, T., Routy, B., Lepage, P., Boneca, I. G., Chamaillard, M., Kroemer, G., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.06.001 · Cited by 1,041
CD28 Costimulation: From Mechanism to Therapy
Esensten, J. H., Helou, Y. A., Chopra, G., Weiss, A., & Bluestone, J. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.020 · Cited by 937
Metadata
- Authors
- Schildberg, F. A., Klein, S. R., Freeman, G. J., & Sharpe, A. H.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 44
- Issue
- 5
- Pages
- 955-972
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2404485673
- Cited by
- 542
- References
- 210
- FWCI
- 29.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.